Skip to main content
Year archive

MAYNE PHARMA GROUP LIMITED — 2019 filings

All 35 regulatory filings released by MAYNE PHARMA GROUP LIMITED (MYX) in 2019, sourced directly from the official regulator.

35 Filings
2019 Period
2019 filings (35)
Filing Released Lang
Employee LTI changes and Appendix 3B 9 pages 425.9KB
Share Issue/Capital Change
2019-12-08 English
Change of Director's Interest Notice 2 pages 278.2KB
Director's Dealing
2019-12-08 English
Final Director's Interest Notice 2 pages 87.1KB
Director's Dealing
2019-11-24 English
2019 AGM Chairman's Address 5 pages 115.0KB
AGM Information
2019-11-21 English
2019 AGM CEO's Speech 7 pages 138.4KB
AGM Information
2019-11-21 English
2019 AGM Presentation 15 pages 692.1KB
AGM Information
2019-11-21 English
Results of Meeting 2 pages 169.2KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-21 English
Mayne Pharma continues expansion of dermatology pipeline 1
Capital/Financing Update
2019-11-18 English
Mayne Pharma completes E4/DRSP transaction and Appendix 3B 9 pages 349.5KB
Capital/Financing Update
2019-11-12 English
E4/DRSP contraceptive presented at EU gynecology conference 2 pages 108.9KB
Regulatory Filings
2019-10-22 English
Notice of Annual General Meeting/Proxy Form 14 pages 715.9KB
AGM Information
2019-10-20 English
Retirement of Director 1 page 101.9KB
Board/Management Information
2019-10-20 English
Change of Director's Interest Notice (x2) 4 pages 197.9KB
Director's Dealing
2019-10-17 English
2019 Annual Report 96 pages 3.1MB
Annual Report
2019-10-13 English
Appendix 4G and Corporate Governance Statement 26 pages 453.2KB
Governance Information
2019-10-13 English
Appendix 3B 9 pages 276.2KB
Capital/Financing Update
2019-10-02 English
MYX signs license agreement for novel oral contraceptive 4 pages 122.2KB
Capital/Financing Update
2019-10-01 English
Appendix 3B 9 pages 278.2KB
Share Issue/Capital Change
2019-09-29 English
Lapse of employee options 1 page 163.2KB
Transaction in Own Shares
2019-09-15 English
PBS listing for KAPANOL in chronic breathlessness 3 pages 121.1KB
Regulatory Filings
2019-08-26 English
Appendix 4E and Full Year Statutory Accounts 77 pages 1.7MB
Annual Report
2019-08-22 English
2019 Full Year Results Media Release 5 pages 169.1KB
Earnings Release
2019-08-22 English
2019 Full Year Results Investor Presentation 29 pages 1.1MB
Investor Presentation
2019-08-22 English
Change in substantial holding 7 pages 256.6KB
Major Shareholding Notification
2019-07-29 English
Lapse of employee options 1 page 155.8KB
Transaction in Own Shares
2019-07-03 English
Change in substantial holding 7 pages 164.7KB
Regulatory Filings
2019-05-20 English
Mayne Pharma market update 5 pages 283.5KB
Interim / Quarterly Report
2019-05-13 English
Mayne Pharma investor presentation to Goldmans conference 21 pages 5.2MB
Investor Presentation
2019-04-03 English
Change in substantial holding 9 pages 352.2KB
Regulatory Filings
2019-03-13 English
Half Year Accounts 36 pages 1.4MB
Interim / Quarterly Report
2019-02-21 English
2019 Half Year Media Release 5 pages 439.9KB
Interim / Quarterly Report
2019-02-21 English
2019 Half Year Investor Presentation 35 pages 1.4MB
Investor Presentation
2019-02-21 English
Mayne Pharma announces new indication for Kapanol by TGA 3 pages 423.6KB
Regulatory Filings
2019-02-18 English
Lexette (halobetasol) foam now launched in the US 2 pages 259.2KB
Regulatory Filings
2019-02-12 English
Tolsura (SUBA-itraconazole) capsule now launched in the US 3 pages 457.3KB
Regulatory Filings
2019-01-29 English